MedPath

Impact of a Communication Strategy in the Prevention of Depressive Symptoms in Patients with Covid-19

Not Applicable
Completed
Conditions
Covid19
Critical Illness
Mechanical Ventilation
Interventions
Behavioral: Intervention. Early and integral communication strategy (EICS)
Registration Number
NCT05035563
Lead Sponsor
Pontificia Universidad Catolica de Chile
Brief Summary

The purpose of this study is to compare the effect of an early and integral communication strategy (EICS) versus standard care, on the rate of depressive symptoms at 3 months after discharge from the ICU, in patients with severe Covid-19, their family members and health personnel.

Evaluating the rate of depressive symptoms at 3 months after discharge from the ICU, with a) Hospital Anxiety and Depression, b) Posttraumatic Stress Disorder Checklist (S)

Detailed Description

We designed a pre-post intervention study, the groups were non-randomly allocated.

The study is implementation in 10 Chilean hospitals, admitting 350 patients.

Pre-intervention: The practices of each ICU will be maintained, until the moment that according to randomization corresponds the beginning of the intervention, in each center.

Post-intervention: EICS to facilitate communication between the family, patient and health team, through written material, via the web (tablet and webmaster) and by telephone.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
350
Inclusion Criteria
  • Adults> 18 years old
  • Admitted to the ICU
  • Requiring Mechanical Ventilation> 12 hrs due to COVID-19
Exclusion Criteria
  • Patients with therapeutic proportionality is defined early
  • Patients with communication limitations (they do not speak Spanish) are excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Early and integral communication strategy (EICS) (Post-intervention)Intervention. Early and integral communication strategy (EICS)EICS that includes a bundle of various strategies that allow to favor communication and contact between family members, patients and health team. That considers the delivery of: (1) Receive timely and understandable information; (2) Receive visits, companionship, and spiritual assistance
Primary Outcome Measures
NameTimeMethod
Rate of depressive symptomsThird month post-discharge from ICU

The rate of depressive symptoms after discharge from the ICU will be evaluated in patients with severe Covid-19, their relatives and health personnel with the instrument HADS (Hospital Anxiety and Depression Scale)

Secondary Outcome Measures
NameTimeMethod
Risk factors of depressive symptomsThird month post-discharge from ICU

Identify risk factors associated with depressive symptoms at 3 months post ICU in patients with severe Covid-19, their relatives and health team. Considering physical health, mental health and sociodemographic factors.

To measure depressive symptoms will be used Hospital Anxiety and Depression Scale (HADS), total scores for depression range from 0 to 21, categorized as: normal (0-7), mild (8-10), moderate (11-14) or severe (15-21)

Cognition status post-ICUTwelfth month post-discharge from ICU

MOCA blind instrument will be applied to patients.

ICU memories post ICUTwelfth month post-discharge from ICU

ICU Memory Tool (ICUMT) will be applied to patients.In ICUMT, memories are categorized in subscales of factual memories, memories of feelings, and memories of delusion

Functional independence post-ICUTwelfth month post-discharge from ICU

Barthel will be used in patients

Post traumatic stress post-ICUTwelfth month post-discharge from ICU

This mental health condition will be evaluated in patients, family members and the health team, with the instrument Impact of Event Scale Revised (IES-R).

Functionality Status post-ICUTwelfth month post-discharge from ICU

Post-COVID-19 Functional Status (PCFS) will be used in patients

Anxiety post ICUTwelfth month post-discharge from ICU

This mental health condition will be evaluated in patients, family members and the health team

Quality of life post ICUTwelfth month post-discharge from ICU

Euro Qol (EQ-5D) will be applied to patients.

Rate of depressive symptomsTwelfth month post-discharge from ICU

The rate of depressive symptoms after discharge from the ICU will be evaluated in patients with severe Covid-19, their relatives and health personnel with the instrument HADS (Hospital Anxiety and Depression Scale)

Trial Locations

Locations (1)

Pontificia Universidad Católica de Chile - Medicina

🇨🇱

Santiago, Metropolitana, Chile

© Copyright 2025. All Rights Reserved by MedPath